Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tiziana Cavallini"'
Autor:
Letizia Trincavelli, Pier Luigi Ferrarini, Gino Giannaccini, Gabriella Maria Pia Ortore, Adriano Martinelli, Giuseppe Saccomanni, Laura Betti, Tiziana Cavallini, Clementina Manera, Tiziano Tuccinardi
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 15:4604-4610
A series of 1,8-naphthyridine derivatives bearing various substituents in position 3, 4, and 7 of the heterocyclic nucleus have been synthesized and evaluated for their affinity at the bovine and human adenosine receptors. The new compounds were foun
Autor:
Tiziano Tuccinardi, Giuseppe Saccomanni, Antonio Lucacchini, Gabriella Maria Pia Ortore, Pier Luigi Ferrarini, Laura Betti, Adriano Martinelli, Gino Giannaccini, Tiziana Cavallini, Clementina Manera
Publikováno v:
Journal of Medicinal Chemistry. 47:3019-3031
A new series of 1,8-naphthyridine derivatives (29-44 and 46-52) bearing various substituents in different positions on the heterocyclic nucleus were synthesized in order to analyze the effects produced on the affinity toward the bovine adenosine rece
Autor:
Clementina Manera, Tiziana Cavallini, Muwaffag Badawneh, Laura Bellini, Giuseppe Saccomanni, Pier Luigi Ferrarini, Jalal A. Al jamal
Publikováno v:
Farmaco (Societa chimica italiana : 1989). 58(9)
A series of 3- or 4-phenyl-1,8-naphthyridine derivatives variously substituted in the positions 2, 6 and 7 were synthesized and evaluated for in vitro evaluation for their antimycobacterial activity as part of a TAACF TB screening program under the d
Autor:
Tiziana Cavallini, Gian Luigi Gessa, Luca Pani, Pier Luigi Ferrarini, Vincenzo Calderone, Stefania Ruiu, Giuseppe Saccomanni, Clementina Manera
Publikováno v:
Bioorganicmedicinal chemistry. 12(8)
Cannabinoid receptors have been studied extensively in view of their potential functional role in several physiological and pathological processes. For this reason, the search for new potent, selective ligands for subtype CB receptors, CB(1) and CB(2
Autor:
Giuseppe Saccomanni, Tiziana Cavallini, Rosamiria Greco, Clementina Manera, Pier Luigi Ferrarini, Vincenzo Calderone, Barbara Adinolfi, Muwaffag Badawneh, Lara Testai
Drugs acting on beta(1)- and beta(2)-adrenergic receptors are widely used for the clinical management of a large number of cardiovascular and respiratory pathologies. In the last decade, the discovery of the third subtype of beta receptors, the beta(
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f26739c39025aa03990924925cfcb3f4
http://hdl.handle.net/11568/81172
http://hdl.handle.net/11568/81172